4MXV image
Entry Detail
PDB ID:
4MXV
Title:
Structure of Lymphotoxin alpha bound to anti-LTa Fab
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2013-09-26
Release Date:
2013-11-13
Method Details:
Experimental Method:
Resolution:
3.20 Å
R-Value Free:
0.23
R-Value Work:
0.17
R-Value Observed:
0.18
Space Group:
P 41 21 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Lymphotoxin-alpha
Chain IDs:A, B, C (auth: D)
Chain Length:157
Number of Molecules:3
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:anti-Lymphotoxin alpha antibody light chain
Chain IDs:D (auth: E), F (auth: L), H (auth: X)
Chain Length:211
Number of Molecules:3
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:anti-Lymphotoxin alpha antibody heavy chain
Chain IDs:E (auth: F), G (auth: H), I (auth: Y)
Chain Length:213
Number of Molecules:3
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Dimerization of LT beta R by LT alpha 1 beta 2 is necessary and sufficient for signal transduction.
Proc.Natl.Acad.Sci.USA 110 19896 19901 (2013)
PMID: 24248355 DOI: 10.1073/pnas.1310838110

Abstact

Homotrimeric TNF superfamily ligands signal by inducing trimers of their cognate receptors. As a biologically active heterotrimer, Lymphotoxin(LT)α1β2 is unique in the TNF superfamily. How the three unique potential receptor-binding interfaces in LTα1β2 trigger signaling via LTβ Receptor (LTβR) resulting in lymphoid organogenesis and propagation of inflammatory signals is poorly understood. Here we show that LTα1β2 possesses two binding sites for LTβR with distinct affinities and that dimerization of LTβR by LTα1β2 is necessary and sufficient for signal transduction. The crystal structure of a complex formed by LTα1β2, LTβR, and the fab fragment of an antibody that blocks LTβR activation reveals the lower affinity receptor-binding site. Mutations targeting each potential receptor-binding site in an engineered single-chain variant of LTα1β2 reveal the high-affinity site. NF-κB reporter assays further validate that disruption of receptor interactions at either site is sufficient to prevent signaling via LTβR.

Legend

Protein

Chemical

Disease

Primary Citation of related structures